However, distinct PPP2R1A missense mutations might affect B subunit binding and PP2A activity in a slightly different way (102), thereby, in part, contributing to a different tumor biology in type I and II ECs as well as other cancers. This evidence concerns the gene PPP2R1A and neoplasm.